450 related articles for article (PubMed ID: 24468999)
1. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi.
Tenthani L; Haas AD; Tweya H; Jahn A; van Oosterhout JJ; Chimbwandira F; Chirwa Z; Ng'ambi W; Bakali A; Phiri S; Myer L; Valeri F; Zwahlen M; Wandeler G; Keiser O
AIDS; 2014 Feb; 28(4):589-598. PubMed ID: 24468999
[TBL] [Abstract][Full Text] [Related]
2. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.
Haas AD; Tenthani L; Msukwa MT; Tal K; Jahn A; Gadabu OJ; Spoerri A; Chimbwandira F; van Oosterhout JJ; Keiser O
Lancet HIV; 2016 Apr; 3(4):e175-82. PubMed ID: 27036993
[TBL] [Abstract][Full Text] [Related]
3. Towards elimination of mother-to-child transmission of HIV: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in Malawi (Option B+).
van Lettow M; Bedell R; Mayuni I; Mateyu G; Landes M; Chan AK; van Schoor V; Beyene T; Harries AD; Chu S; Mganga A; van Oosterhout JJ
J Int AIDS Soc; 2014; 17(1):18994. PubMed ID: 25079437
[TBL] [Abstract][Full Text] [Related]
4. Impact of universal antiretroviral therapy for pregnant and postpartum women on antiretroviral therapy uptake and retention.
Abrams EJ; Langwenya N; Gachuhi A; Zerbe A; Nuwagaba-Biribonwoha H; Mthethwa-Hleta S; Sahabo R; Lesosky M; Okello V; Myer L
AIDS; 2019 Jan; 33(1):45-54. PubMed ID: 30289804
[TBL] [Abstract][Full Text] [Related]
5. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
[TBL] [Abstract][Full Text] [Related]
6. Implementation of Antiretroviral Therapy for Life in Pregnant/Breastfeeding HIV+ Women (Option B+) Alongside Rollout and Changing Guidelines for ART Initiation in Rural Zimbabwe: The Lablite Project Experience.
Ford D; Muzambi M; Nkhata MJ; Abongomera G; Joseph S; Ndlovu M; Mabugu T; Grundy C; Chan AK; Cataldo F; Kityo C; Seeley J; Katabira E; Gilks CF; Reid A; Hakim J; Gibb DM;
J Acquir Immune Defic Syndr; 2017 Apr; 74(5):508-516. PubMed ID: 27984555
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and outcomes of women initiating ART during pregnancy versus breastfeeding in Option B+ in Malawi.
Landes M; Sodhi S; Matengeni A; Meaney C; van Lettow M; Chan AK; van Oosterhout JJ
BMC Public Health; 2016 Aug; 15():713. PubMed ID: 27487775
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of Option B+ ART in Malawi: few severe maternal toxicity events or infant HIV infections among pregnant women initiating tenofovir/lamivudine/efavirenz.
Harrington BJ; DiPrete BL; Jumbe AN; Ngongondo M; Limarzi L; Wallie SD; Chagomerana MB; Hosseinipour MC;
Trop Med Int Health; 2019 Oct; 24(10):1221-1228. PubMed ID: 31381233
[TBL] [Abstract][Full Text] [Related]
9. Cost and cost-effectiveness of transitioning to universal initiation of lifelong antiretroviral therapy for all HIV-positive pregnant and breastfeeding women in Swaziland.
Cunnama L; Abrams EJ; Myer L; Gachuhi A; Dlamini N; Hlophe T; Kikuvi J; Langwenya N; Mthethwa S; Mudonhi D; Nhlabatsi B; Nuwagaba-Biribonwoha H; Okello V; Sahabo R; Zerbe A; Sinanovic E
Trop Med Int Health; 2018 Sep; 23(9):950-959. PubMed ID: 29956426
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Experiences of Women and Health Care Workers in the Context of PMTCT Option B Plus in Malawi.
Cataldo F; Chiwaula L; Nkhata M; van Lettow M; Kasende F; Rosenberg NE; Tweya H; Sampathkumar V; Hosseinipour M; Schouten E; Kapito-Tembo A; Eliya M; Chimbwandira F; Phiri S;
J Acquir Immune Defic Syndr; 2017 Apr; 74(5):517-522. PubMed ID: 28045712
[TBL] [Abstract][Full Text] [Related]
11. Impact of an innovative approach to prevent mother-to-child transmission of HIV--Malawi, July 2011-September 2012.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Mar; 62(8):148-51. PubMed ID: 23446514
[TBL] [Abstract][Full Text] [Related]
12. Program Implementation of Option B+ at a President's Emergency Plan for AIDS Relief-Supported HIV Clinic Improves Clinical Indicators But Not Retention in Care in Mbarara, Uganda.
Miller K; Muyindike W; Matthews LT; Kanyesigye M; Siedner MJ
AIDS Patient Care STDS; 2017 Aug; 31(8):335-341. PubMed ID: 28650703
[TBL] [Abstract][Full Text] [Related]
13. Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's Option B+ Program.
Haas AD; Msukwa MT; Egger M; Tenthani L; Tweya H; Jahn A; Gadabu OJ; Tal K; Salazar-Vizcaya L; Estill J; Spoerri A; Phiri N; Chimbwandira F; van Oosterhout JJ; Keiser O
Clin Infect Dis; 2016 Nov; 63(9):1227-1235. PubMed ID: 27461920
[TBL] [Abstract][Full Text] [Related]
14. Retention of HIV infected pregnant and breastfeeding women on option B+ in Gomba District, Uganda: a retrospective cohort study.
Kiwanuka G; Kiwanuka N; Muneza F; Nabirye J; Oporia F; Odikro MA; Castelnuovo B; Wanyenze RK
BMC Infect Dis; 2018 Oct; 18(1):533. PubMed ID: 30355356
[TBL] [Abstract][Full Text] [Related]
15. Baseline characteristics of study sites and women enrolled in a three-arm cluster randomized controlled trial: PMTCT uptake and retention (pure) Malawi.
van Lettow M; Tweya H; Rosenberg NE; Trapence C; Kayoyo V; Kasende F; Kaunda B; Hosseinipour MC; Eliya M; Cataldo F; Gugsa S; Phiri S;
Reprod Health; 2017 Jul; 14(1):82. PubMed ID: 28693525
[TBL] [Abstract][Full Text] [Related]
16. HIV transmission and retention in care among HIV-exposed children enrolled in Malawi's prevention of mother-to-child transmission programme.
Haas AD; van Oosterhout JJ; Tenthani L; Jahn A; Zwahlen M; Msukwa MT; Davies MA; Tal K; Phiri N; Spoerri A; Chimbwandira F; Egger M; Keiser O
J Int AIDS Soc; 2017 Sep; 20(1):21947. PubMed ID: 28884524
[TBL] [Abstract][Full Text] [Related]
17. Moving toward test and start: learning from the experience of universal antiretroviral therapy programs for HIV-infected pregnant/ breastfeeding women.
Forhan SE; Modi S; Houston JC; Broyles LN
AIDS; 2017 Jun; 31(10):1489-1493. PubMed ID: 28574966
[TBL] [Abstract][Full Text] [Related]
18. Viral Suppression and Retention in Care up to 5 Years After Initiation of Lifelong ART During Pregnancy (Option B+) in Rural Uganda.
Koss CA; Natureeba P; Kwarisiima D; Ogena M; Clark TD; Olwoch P; Cohan D; Okiring J; Charlebois ED; Kamya MR; Havlir DV
J Acquir Immune Defic Syndr; 2017 Mar; 74(3):279-284. PubMed ID: 27828878
[TBL] [Abstract][Full Text] [Related]
19. Understanding factors, outcomes and reasons for loss to follow-up among women in Option B+ PMTCT programme in Lilongwe, Malawi.
Tweya H; Gugsa S; Hosseinipour M; Speight C; Ng'ambi W; Bokosi M; Chikonda J; Chauma A; Khomani P; Phoso M; Mtande T; Phiri S
Trop Med Int Health; 2014 Nov; 19(11):1360-6. PubMed ID: 25087778
[TBL] [Abstract][Full Text] [Related]
20. Retention, transfer out and loss to follow-up two years after delivery in a cohort of HIV+ pregnant women in Malawi.
Giuliano M; Liotta G; Andreotti M; Mancinelli S; Buonomo E; Scarcella P; Amici R; Jere H; Sagno JB; Di Gregorio M; Marazzi MC; Vella S; Palombi L
Int J STD AIDS; 2016 May; 27(6):462-8. PubMed ID: 25953961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
